Postvaccination Immunogenicity of BNT162b2 SARS-CoV-2 Vaccine and Its Predictors in Pediatric Inflammatory Bowel Disease.

Jiri BronskyIvana CopovaMarianna DurilovaDenis KazekaMichal KubatTereza LerchovaEva VlckovaKatarina MitrovaMichal RatajAdam KlocperkAnna SedivaOndrej Hradsky

Published in: Journal of pediatric gastroenterology and nutrition (2022)

Patients with IBD produced higher levels of postvaccination anti-spike S2 antibodies than controls. Previous SARS-CoV-2 infection is associated with higher production of postvaccination antibodies and anti-tumor necrosis factor treatment with lower production.

Keyphrases

sars cov
respiratory syndrome coronavirus
rheumatoid arthritis
coronavirus disease
young adults